Navigation Links
CVS Caremark Charity Classic Golf Tournament Unveils 10th Anniversary Field
Date:4/14/2008

Prestigious Tournament Boasts Impressive Roster of World-Class Golfers Including First-Timers Faldo, Weekley, Snedeker, Howell III, Diaz and

Castrale

WOONSOCKET, R.I., April 14 /PRNewswire/ -- Brad Faxon and Billy Andrade, PGA TOUR Professionals and co-hosts of the CVS Caremark Charity Classic, unveiled the field for the tournament's 10th anniversary edition today. The 2008 CVS Caremark Charity Classic is set for June 22 - 24 at Rhode Island Country Club and will benefit numerous regional charities.

This year, the CVS Caremark Charity Classic will once again draw its notable 20-player field from the ranks of the PGA, LPGA and Champions tours. The announced field represents three countries and includes legendary golfer and three-time Masters Champion Nick Faldo who will be making his inaugural appearance.

Additional tournament newcomers include Boo Weekley, Brandt Snedeker and Charles Howell III. LPGA professionals Laura Diaz and Nicole Castrale are also new to the tournament in 2008. Weekley is currently 25th on the FedEx Cup point standings while 2007 PGA TOUR Rookie of the Year Snedeker has already posted three top-10 finishes this year. Howell III has earned four top-25 finishes to date in 2008.

Continuing the tradition of fielding a women's team, Wake Forest hall-of-famer Diaz, who is currently fifth on the 2008 LPGA Money list, and Castrale, who sunk the winning putt for the 2007 U.S. Solheim Cup team, will compete for the 2008 CVS Caremark Charity Classic trophy. There are three remaining spots in the 2008 field that will be announced soon.

Champions Return

J.J. Henry and Stewart Cink will return to defend their 2007 title. Two-time CVS Caremark Charity Classic Champion Nick Price (2001, 2006) will also compete in the 36-hole team event. Rounding out the roster are Columbian sensation Camilo Villegas; Bubba Watson, who for two consecutive seasons has led the TOUR in driving
'/>"/>

SOURCE CVS Caremark
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Caremark Pharmacy Services Receives New URAC Pharmacy Benefit Management and Drug Therapy Management Accreditations
2. CVS Caremark Celebrates American Pharmacists Month by Thanking Its 20,000 Pharmacists
3. CVS Caremarks Howard McLure Elected New PCMA Board Chairman
4. CVS Caremark All Kids Can and Scholastic Distribute Free Educational Guides in Schools to Champion Acceptance and Build Self-Esteem among Second Graders
5. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark
6. CVS Caremark All Kids Can Program Announces the Opening of a Boundless(TM) Playground in Dallas to Serve Children of all Abilities
7. CVS Caremark Corp. to Pay $36.7 Million to U.S., 23 States, & D.C. to Settle Medicaid Prescription Drug Fraud Allegations
8. Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
9. CVS Caremark Presents at NCOA-ASA Conference on Companys Commitment to Recruiting and Retaining Mature Workers
10. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
11. Celebrity Seating Only! Levitz Chair Signed by 39 Daytime Stars Sells for $1200 on Charitybuzz.com

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...enaCare Holdings has announced that it has become ...e of the largest nonprofit organizations dedicated.... , Delray Beach, FL (Voc...OTCBB: XCHO), a company specializing in the market... products, has announced today that is has become ...
(Date:11/27/2009)... SEATTLE, Nov. 27 Allrecipes.com ... Thanksgiving traffic numbers, with more than 2.8 ...iding a clear picture of what was served on the bi...giving meal in 2009 weighed in at 2,225 calories p...feast. According to the Allrecipes site, Sweet Po...
(Date:11/27/2009)...pecialist manufacturers who use medical load cells...s of dollars by bringing in technology partner Fli...rs of pro-active medical manufacturers are calling... of their projects, ensuring that progress will no...otentially outdated technology. , ...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...art Inc. announced,that the first DuraHeart(TM) Le...in October at the University of Tokyo Hospital in ...ward an early application for approval,for manufac...etically levitated,impeller. The product received ...
...evenue Guidance, HOUSTON, Oct. 31 Cyberonics, In... for Medicare and Medicaid Services,(CMS) has publ...System,(OPPS) Final Rule and Ambulatory Payment Cl...erapy generators and $7,234,for insertion of assoc...
... and Asia-Pacific trials to be, presented at 59th ... Study of Liver Diseases ...ayer HealthCare Pharmaceuticals, Inc. and Onyx Pha...ation for the Study,of Live Diseases (AASLD) demon...
... nurtures creative,thinking. In this time of econo...mers, and employees, innovations in marketing, sal...market share., Network with and learn from leadin...Enable Companies to Survive and Thrive,During the ...
...ing nerves, waking people from a coma, 6 year chro...tigue/fibromyalgia, whiplash, carpel tunnel, and r...using advanced magnetic therapy techniques develop... year chronic sciatica back pain, 15- and 25-year ...
...shed finds that, while about 40 percent of women s...cent indicate that those issues are a source of si...Massachusetts General Hospital (MGH) physician app...se which are truly bothersome and affect a woman,s...
Other Medicine News:Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 2Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 2Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 4Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 5Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 6Health News:Survive the Economic Downturn Through Innovations in Integrated Customer Strategies 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 3Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 4Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 5Health News:While prevalent, sexual problems in women not always associated with distress 2
(Date:11/25/2009)... SAN DIEGO, Nov. 25 NuVa...any focused on developing products for minimally d...nced today that it will host a conference call on ...p.m. PT. The conference call will focus on curren...,s products and will include comments from managem...
(Date:11/25/2009)...EW YORK, Nov. 25 Reportlinker.com ...ilable in its catalogue: ,, Intranasal Drug De...www.reportlinker.com/p0164267/Intranasal-Drug-Deli...US intranasal drug delivery market is witnessing a...elivery of conventional local therapeutic drugs to...
(Date:11/25/2009)... VIEW, Calif., Nov. 25 ChemoCent...cal data from the Company,s PROTECT-1 (the Prospec... disease Trial) of Traficet-EN(TM) (CCX282-B) in p...monstrated clinical efficacy with a favorable safe...ed evidence of clinical efficacy in the reduction ...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Dense Breasts Raise Risk of Cancer Recurrence 60997 1Dense Breasts Raise Risk of Cancer Recurrence 60997 2Dense Breasts Raise Risk of Cancer Recurrence 60997 3Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 1Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 2Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 60994 3American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 1American Academy of Physician Assistants Applauds U S House of Representatives for Passing Health Care Reform Bill 60989 2
... 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. an...enter Phase 2 trial of the triplet combination of ... and paclitaxel will be,presented at the 98th annu...Research (AACR) in Los Angeles. Preclinical studie...tic cancer cell growth,inhibition with TELCYTA in ...
...SS WIRE)--Apr 11, 2007 - New data,supporting the c...,the most advanced investigational oral protease i...HCV) infection, will be presented,at the 42nd Annu...dy of the Liver (EASL) in Barcelona this week. In ...een accepted for presentation,at the EASL conferen...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
ACE SCFE Screw
4.0 mm and 6.5 mm Cannulated Screws
...bles fixation of humeral shaft fractures while avo...associated with antegrade nailing. , ,In addition,...ng using a nail-mounted targeting device. This dev...th the patient in the prone position. In cases tha...
...edical technology company and a key participant in...es a new generation Automated Coagulation Timer. T...electromechanical coagulation instrument designed ... citrated whole blood, and plasma samples. Clottin...
Medicine Products: